Fifty years of the pericardial valve: Long-term results in the aortic position.
aortic valve
clinical review
pericardial heart valve
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
revised:
23
03
2021
received:
11
01
2021
accepted:
18
04
2021
pubmed:
14
5
2021
medline:
14
7
2021
entrez:
13
5
2021
Statut:
ppublish
Résumé
It is now 50 years since the development of the first pericardial valve in 1971. In this time significant progress has been made in refining valve design aimed at improving the longevity of the prostheses. This article reviews the current literature regarding the longevity of pericardial heart valves in the aortic position. Side by side comparisons of freedom from structural valve degeneration are made for the valves most commonly used in clinical practice today, including stented, stentless, and sutureless valves. Strategies to reduce structural valve degeneration are also discussed including methods of tissue fixation and anti-calcification, ways to minimise mechanical stress on the valve, and the role of patient prosthesis mismatch.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2865-2875Informations de copyright
© 2021 The Authors. Journal of Cardiac Surgery Published by Wiley Periodicals LLC.
Références
Ionescu MI , Tandon AP , Mary DAS , Abid A , McGoon DC . Heart valve replacement with the Ionescu-Shiley pericardial xenograft. J Thorac Cardiovasc Surg. 1977;73(1):31-42.
Wheatley DJ , Crawford FA , Kay PH , et al. A ten-year study of the Ionescu-Shiley low-profile bioprosthetic heart valve. Eur J Cardiothorac Surg. 1994;8(10):541-548.
Ott DA , Coelho AT , Cooley DA , Reul GJ Jr. Ionescu-Shiley pericardial xenograft valve: hemodynamic evaluation and early clinical follow-up of 326 patients. Cardiovasc Dis. 1980;7(2):137-48.
Reul GJ Jr. , Cooley DA , Duncan JM , et al. Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patients. J Vasc Surg. 1985;2(1):192-204.
Walley VM , Keon WJ . Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg. 1987;93(6):925-933.
Bodnar E , Olsen EG , Ross DN . Observations on glutaraldehyde-treated heterologous cardiac valves. Thorax. 1979;34(6):794-800.
Nimni ME . The cross-linking and structure modification of the collagen matrix in the design of cardiovascular prosthesis. J Card Surg. 1988;3(4):523-533.
Broom ND , Thomson FJ . Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves: towards a more scientific basis. Thorax. 1979;34(2):166-176.
Vesely I , Boughner D , Song T . Tissue buckling as a mechanism of bioprosthetic valve failure. Ann Thorac Surg. 1988;46(3):302-308.
Jaffe WM , Barratt-Boyes BG , Sadri A , Gavin JB , Coverdale HA , Neutze JM . Early follow-up of patients with the Medtronic Intact porcine valve. A new cardiac bioprosthesis. J Thorac Cardiovasc Surg. 1989;98(2):181-192.
Barratt-Boyes BG , Jaffe WM , Whitlock RM . The Medtronic Intact* porcine valve: Ten-year clinical review. J Thorac Cardiovasc Surg. 1998;116(6):1005-1014.
Manji RA , Zhu LF , Nijjar NK , et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114(4):318-327.
Pathak CP , Adams AK , Simpson T , Phillips RE Jr. , Moore MA Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. J Biomed Mater Res A. 2004;69(1):140-144.
Cunanan CM , Cabiling CM , Dinh TT , et al. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg. 2001;71(5 Suppl):S417-S421.
Dove JS, Howanec M, Thubrikar ME. eds. Carpentier-Edwards ThermaFix Process: A Method for Extracting Calcium Binding Sites from Pericardial Tissue; 2006.
Flameng W , Hermans H , Verbeken E , Meuris B . A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model. J Thorac Cardiovasc Surg. 2015;149(1):340-345.
Puskas JD , Bavaria JE , Svensson LG , et al. The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue. Eur J Cardiothorac Surg. 2017;52(3):432-439.
Johnston DR , Griffith BP , Puskas JD , Bavaria JE , Svensson LG . Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissue. J Thorac Cardiovasc Surg. 2020;25:329-349.
Vyavahare N , Hirsch D , Lerner E , et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Circulation. 1997;95(2):479-488.
Vyavahare NR , Hirsch D , Lerner E , et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998;40(4):577-585.
Schoen FJ , Levy RJ . Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47(4):439-465.
Vesely I , Barber JE , Ratliff NB . Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure. J Heart Valve Dis. 2001;10(4):471-477.
Sacks MS , Schoen FJ . Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res. 2002;62(3):359-371.
Christie GW . Computer modelling of bioprosthetic heart valves. Eur J Cardiothorac Surg. 1992;6(Suppl 1):S95-S100.
Flameng W , Rega F , Vercalsteren M , Herijgers P , Meuris B . Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J Thorac Cardiovasc Surg. 2014;147(4):1219-1224.
Urso S , Calderón P , Sadaba R , et al. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration. J Card Surg. 2014;29(4):439-444.
Otto CM , Nishimura RA , Bonow RO , et al. ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: executive summary: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;2021 143(5):e35-e71.
Rafiq S , Steinbrüchel DA , Lilleør NB , et al. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial. Thromb Res. 2017;150:104-110.
Brennan JM , Edwards FH , Zhao Y , et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol. 2012;60(11):971-977.
Mérie C , Køber L , Skov Olsen P , et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA. 2012;308(20):2118-2125.
Fatima B , Mohananey D , Khan FW , et al. Durability data for bioprosthetic surgical aortic valve: a systematic review. JAMA Cardiology. 2019;4(1):71-80.
Dvir D , Bourguignon T , Otto CM , et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018;137(4):388-399.
Grunkemeier GL , Eric Jamieson WR , Miller DC , Starr A . Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg. 1994;108(4):709-718.
Zhigalov K , Sá M , Gogia I , et al. Outcomes and hemodynamics of Enable bioprosthesis in 432 patients: an afterword. Minim Invasive Ther Allied Technol. 2020:1-6.
Shrestha M , Fischlein T , Meuris B , et al. European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients. Eur J Cardiothorac Surg. 2016;49(1):234-241.
Conte J , Weissman N , Dearani JA , et al. A North American, Prospective, Multicenter Assessment of the mitroflow aortic pericardial prosthesis. Ann Thorac Surg. 2010;90(1):144-52.e3.
Szecel D , Eurlings R , Rega F , Verbrugghe P , Meuris B Perceval sutureless aortic valve implantation: mid-term outcomes. Ann Thorac Surg. 2020;111:1331-1337.
Glauber M , Di Bacco L , Cuenca J , et al. Minimally invasive aortic valve replacement with sutureless valves: results from an International Prospective Registry. Innovations. 2020;15(2):120-130.
Wendt D , Thielmann M , Plicht B , et al. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority? J Thorac Cardiovasc Surg. 2014;147(5):1553-1560.
Baert J , Astarci P , Noirhomme P , de Kerchove L . The risk of oversizing with sutureless bioprosthesis in small aortic annulus. J Thorac Cardiovasc Surg. 2017;153(2):270-272.
Sénage T , Le Tourneau T , Foucher Y , et al. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients. Circulation. 2014;130(23):2012-2020.
Bourguignon T , Bouquiaux-Stablo AL , Candolfi P , et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg. 2015;99(3):831-837.
Ugur M , Suri RM , Daly RC , et al. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses. J Thorac Cardiovasc Surg. 2014;148(5):1940-1946.
Modi A , Pousios D , Sadeque S , et al. Early in-vivo hemodynamic comparison of supra-annular aortic bioprostheses: Trifecta versus Perimount Magna Ease. J Heart Valve Dis. 2014;23(3):325-332.
Meuris B , Marynissen M , Verstraeten L , Szecel D , Verbrugghe P . Abstract 12791: oversizing in sutureless aortic heart valves leads to higher gradients and increased pacemaker rates. Circulation. 2019;140(Suppl_1):A12791.
Johnston DR , Soltesz EG , Vakil N , et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99(4):1239-1247.
Laufer G , Haverich A , Andreas M , et al. Long-term outcomes of a rapid deployment aortic valve: data up to 5 years†. Eur J Cardiothorac Surg. 2017;52(2):281-287.
Mosquera VX , Bouzas-Mosquera A , Velasco-García C , et al. Long-term outcomes and durability of the mitroflow aortic bioprosthesis. J Card Surg. 2016;31(5):264-273.
Minami K , Zittermann A , Schulte-Eistrup S , Koertke H , Körfer R . Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg. 2005;80(5):1699-1705.
Piccardo A , Blossier JD , Le Guyader A , et al. Fate of aortic bioprostheses: an 18-year experience. J Thorac Cardiovasc Surg. 2016;151(3):754-61.e1.
Rodriguez-Gabella T , Voisine P , Puri R , Pibarot P , Rodés-Cabau J . Aortic Bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol. 2017;70(8):1013-1028.
Anselmi A , Ruggieri VG , Lelong B , et al. Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement. J Thorac Cardiovasc Surg. 2017;153(1):21-8.e1.
Lehmann S , Jawad K , Dieterlen MT , et al. Durability and clinical experience using a bovine pericardial prosthetic aortic valve. J Thorac Cardiovasc Surg. 2019;161:1742-1749.
Bavaria JE , Desai ND , Cheung A , et al. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. J Thorac Cardiovasc Surg. 2014;147(2):590-597.
Goldman S , Cheung A , Bavaria JE , Petracek MR , Groh MA , Schaff HV . Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve. J Thorac Cardiovasc Surg. 2017;153(3):561-9.e2.
Fukuhara S , Shiomi S , Yang B , et al. Early structural valve degeneration of trifecta bioprosthesis. Ann Thorac Surg. 2020;109(3):720-727.
Coti I , Haberl T , Scherzer S , et al. Outcome of rapid deployment aortic valves: long-term experience after 700 implants. Ann Cardiothorac Surg. 2020;9(4):314-321.
Jamieson WR , Germann E , Aupart MR , Neville PH , Marchand MA , Fradet GJ . 15-year comparison of supra-annular porcine and PERIMOUNT aortic bioprostheses. Asian Cardiovasc Thorac Ann. 2006;14(3):200-205.
Nielsen PH , Hjortdal V , Modrau IS , et al. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients. Eur J Cardiothorac Surg. 2016;49(6):1705-1710.
Lam KY , Koene B , Timmermans N , Soliman-Hamad M , van Straten A . Reintervention after aortic valve replacement: comparison of 3 aortic bioprostheses. Ann Thorac Surg. 2020;110(2):615-621.
Biancari F , Valtola A , Juvonen T , et al. Trifecta versus perimount magna ease aortic valve prostheses. Ann Thorac Surg. 2020;110(3):879-888.
Repossini A , Fischlein T , Santarpino G , et al. Pericardial stentless valve for aortic valve replacement: long-term results. Ann Thorac Surg. 2016;102(6):1956-65.
Cerqueira RJ , Raimundo R , Moreira S , et al. Freedom Solo® versus Trifecta® bioprostheses: clinical and haemodynamic evaluation after propensity score matching. Eur J Cardiothorac Surg. 2018;53(6):1264-1271.
ViV Aortic. UBQO Limited. 2018;Version 5.
Meuris B , Borger MA , Bourguignon T , et al. Durability of bioprosthetic aortic valves in patients under the age of 60 years - rationale and design of the international INDURE registry. J Cardiothorac Surg. 2020;15(1):119.
Stanger O , Bleuel I , Gisler F , et al. The Freedom Solo pericardial stentless valve: Single-center experience, outcomes, and long-term durability. J Thorac Cardiovasc Surg. 2015;150(1):70-77.
Sponga S , Barbera MD , Pavoni D , et al. Ten-year results of the Freedom Solo stentless heart valve: excellent haemodynamics but progressive valve dysfunction in the long term. Interact Cardiovasc Thorac Surg. 2017;24(5):663-669.
Borger MA , Prasongsukarn K , Armstrong S , Feindel CM , David TE . Stentless aortic valve reoperations: a surgical challenge. Ann Thorac Surg. 2007;84(3):737-743discussion 43-4.
Shinn SH , Altarabsheh SE , Deo SV , Sabik JH , Markowitz AH , Park SJ A systemic review and meta-analysis of sutureless aortic valve replacement versus transcatheter aortic valve implantation. Ann Thorac Surg. 2018;106(3):924-929.
Wahlers TC , Haverich A , Borger MA , et al. Early outcomes after isolated aortic valve replacement with rapid deployment aortic valve. J Thorac Cardiovasc Surg. 2016;151(6):1639-1647.
Englberger L , Carrel TP , Doss M , et al. Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study. J Thorac Cardiovasc Surg. 2014;148(4):1681-1687.